Company Profiles

driven by the PitchBook Platform

Aprea

Description

Developer of target specific drugs for the treatment of cancer with non-functional p53. The company develops the novel anticancer compounds by targeting the tumor suppressor protein p53.

2003

Founded

PRIVATE

Status

11-50

Employees

Series B

Latest Deal Type

$30M

Latest Deal Amount

$34M

Total Amount Raised

Description

Developer of target specific drugs for the treatment of cancer with non-functional p53. The company develops the novel anticancer compounds by targeting the tumor suppressor protein p53.

Website:

www.aprea.com

Ownership Status

Privately held (backing)

Financing Status

Venture Capital-Backed

Primary Industry

Drug Discovery

Other Industries

Pharmaceuticals

Primary Office

Karolinska Institutet Science Park Nobels väg 3 171 65 SolnaSweden +46 (0)8 508 84 50 4
Request a free trial to the PitchBook Platform
You're viewing a free company profile from the PitchBook Platform. To explore Aprea's full profile, request a free trial.

Aprea Valuation and Funding

Request access
Deal TypeDateAmountRaised to DatePost-ValStatusStage

Aprea Investors (10)

Request access
Investor NameInvestor TypeHoldingInvestor SinceParticipating RoundsBoard
Seat
Contact
Info
5AM VenturesVenture CapitalMinority000 0000000 0000
b-to-v PartnersVenture CapitalMinority000 0000000 0000
HealthCapVenture CapitalMinority000 0000000 0000
IndustrifondenVenture CapitalMinority000 0000000 0000
Karolinska DevelopmentVenture CapitalMinority000 0000000 0000
5AM Ventures Venture Capital
b-to-v Partners Venture Capital
HealthCap Venture Capital
Industrifonden Venture Capital
Karolinska Development Venture Capital

Aprea Executive Team (10)

NameTitleBoard
Seat
Contact
Info
Christian SchadePresident & Chief Executive Officer
Ulf BjorklundChief Executive Officer
Kimmo SinervoChief Financial Officer, Executive, Business Administration & Consultant
Lars Abrahmsen Ph.DChief Scientific Officer
Galina SelivanovaCo-Founder & Deputy Director
Christian Schade President & Chief Executive Officer
Ulf Bjorklund Chief Executive Officer
Kimmo Sinervo Chief Financial Officer, Executive, Business Administration & Consultant
Lars Abrahmsen Ph.D Chief Scientific Officer
Galina Selivanova Co-Founder & Deputy Director

Aprea Board Members (9)

NameRepresentingRoleSinceContact
Info
Bernd Seizinger Ph.DSelfExecutive Chairman000 0000
Guido Magni MDVersant VenturesPartner & Managing Director000 0000
Johan Christenson Ph.DHealthCapPartner000 0000
Jonathan Hepple Ph.DRosetta Capital(London)Partner000 0000
Klas Wiman Ph.DSelfBoard Member & Co-Founder000 0000
Bernd Seizinger Ph.D Executive Chairman Self
Guido Magni MD Partner & Managing Director Versant Ventures
Johan Christenson Ph.D Partner HealthCap
Jonathan Hepple Ph.D Partner Rosetta Capital(London)
Klas Wiman Ph.D Board Member & Co-Founder Self
Request full access to PitchBook